Objective: To investigate the relative bioavailability and bioequivalence, in fasting and fed conditions, of repeated doses of two omeprazole enteric-coated formulations in healthy volunteers.

BioNxt reports expansion of its next-generation product pipeline with innovative solutions for autoimmune diseases and longevity: Vancouver, BC Wednesday, November 27, 2024, 17:00 ...